Skip to main content
Research
  1. Queen Mary University of London
  2. Research
  3. Publications

Publications: Dr Nicola Vickaryous

Back to Search
( 2024 ) . Plasma proteomic profiles of UK Biobank participants with multiple sclerosis . Annals of Clinical and Translational Neurology vol. 11 , ( 3 ) 698 - 709 .
Dobson R ( 2023 ) . A phase 2 open-label clinical trial to determine the effect of Famciclovir on Epstein-Barr virus activity as measured by EBV shedding in the saliva of patients with Multiple Sclerosis . Multiple Sclerosis Journal
Dobson R ( 2023 ) . Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination . Multiple Sclerosis Journal
Tallantyre E, Vickaryous N, Richards A, Rios F, George K, Scurr M, Loveless S ( 2022 ) . T-cell response following COVID booster vaccination in seronegative people with multiple sclerosis . Journal of Neurology Neurosurgery & Psychiatry . vol. 93 ,
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N et al. ( 2022 ) . Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis . Multiple Sclerosis and Related Disorders vol. 64 ,
Dobson R, Baker D, Kang A, Schmierer K, Giovannoni G ( 2021 ) . COVID-19 vaccine response in people with multiple sclerosis . Annals of Neurology
( 2020 ) . Remote testing of vitamin D levels across the UK MS population—A case control study . PLOS ONE vol. 15 , ( 12 )
( 2020 ) . Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom . BMC Public Health vol. 20 , ( 1 )
Vickaryous N, Polanco-Echeverry G, Morrow S, Suraweera N, Thomas H, Tomlinson I, Silver A ( 2008 ) . Smooth-muscle myosin mutations in hereditary non-polyposis colorectal cancer syndrome . Br J Cancer vol. 99 , ( 10 ) 1726 - 1728 .
McCart AE, Vickaryous NK ( 2008 ) . Apc mice: Models, modifiers and mutants . Pathology - Research and Practice vol. 204 , ( 7 ) 479 - 490 .
Dobson R, Holden D, Vickaryous N, Bestwick J, George K, Sayali T, Bianchi L, Wafa M et al. . A phase 2 open-label clinical trial to determine the effect of Famciclovir on Epstein-Barr virus activity as measured by EBV shedding in the saliva of patients with Multiple Sclerosis .
. Remote testing of vitamin D levels across the UK MS population – a case control study .
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N et al. . Response to COVID-19 booster vaccinations in seronegative people with MS .
. Vitamin D Genetic Risk Scores in Multiple Sclerosis . Journal of Neurology
Back to Search